Skip to main content
. 2019 Dec 27;9:19909. doi: 10.1038/s41598-019-56356-4

Table 1.

Univariable and multivariable analyses for determining factors correlated to PDC establishment.

Variate PDC establishment Pa OR (95% CI)
No (n = 73) Yes (n = 23)
Univariate analysis
Age 57 (19–88) 57 (19–77) 0.6031b
Gender 0.7585 (0.2647–2.1520)
   Female 40 (78.4%) 11 (21.6%) 0.6352
   Male 33 (73.3%) 12 (26.7%)
Prior therapy 0.3005 (0.0206–4.3759)
   Yes 71 (77.2%) 21 (22.8%) 0.2417
   No 2 (50.0%) 2 (50.0%)
Prior chemotherapy 0.4745 (0.1626–1.3841)
   Yes 51 (81.0%) 12 (19.0%) 0.1367
   No 22 (66.7%) 11 (33.3%)
Prior TKI therapy 1.0289 (0.2727–4.8489)
   Yes 60 (75.9%) 19 (24.1%) 1
   No 13 (76.5%) 4 (23.5%)
EGFR mutation 0.5904 (0.1994–1.8049)
   Yes 53 (79.1%) 14 (20.9%) 0.3064
   No 20 (69.0%) 9 (31.0%)
ALK fusion 0.9455 (0.1524–4.1794)
   Yes 10 (76.9%) 3 (23.1%) 1
   No 63 (75.9%) 20 (24.1%)
ROS1 fusion 3.0575 (0.6588–13.6332)
   Yes 6 (54.5%) 5 (45.5%) 0.1259
   No 67 (78.8%) 18 (21.2%)
Source 1.9584 (0.2184–94.6450)
   Pleural effusion 67 (75.3%) 22 (24.7%) 1
   Others 6 (85.7%) 1 (14.3%)
Time to processing 1.9584 (0.2184–94.6450)
   <4 hours 67 (75.3%) 22 (24.7%) 1
   >24 hours 6 (85.7%) 1 (14.3%)
Sample volume 200 (10–1350) 200 (60–500) 0.58232b
Cytology 8.3654 (2.1991–47.7354)
   Malignancy 32 (61.5%) 20 (38.5%) <0.001
   Others 41 (93.2%) 3 (6.8%)
Tumor colony formation 22.0772 (3.2262–953.2819)
   Yes 36 (62.1%) 22 (37.9%) <0.001
   No 37 (97.4%) 1 (2.6%)
Multivariate analysisc
Variate P OR (95% CI)
Malignancy vs others 0.0239 4.8336 (1.2322–18.9608)
Tumor colony formation vs no colony formation 0.0131 14.1733 (1.7469–114.9934)

aThe P value is calculated using the Fisher’s exact test unless indicated otherwise.

bThe P value is calculated with the Mann-Whitney U test.

cThe P value and odd ratio are analyzed by multivariate logistic regression.

PDC, patient-derived cells.